SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-138529
Filing Date
2021-11-15
Accepted
2021-11-15 07:18:58
Documents
44
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132711d1_8k.htm   iXBRL 8-K 29185
2 EXHIBIT 99.1 tm2132711d1_ex99-1.htm EX-99.1 83012
3 EXHIBIT 99.2 tm2132711d1_ex99-2.htm EX-99.2 39939
7 GRAPHIC tm2132711d1_ex99-1img001.jpg GRAPHIC 12505
8 GRAPHIC tm2132711d1_ex99-2img001.jpg GRAPHIC 523905
9 GRAPHIC tm2132711d1_ex99-2img002.jpg GRAPHIC 385191
10 GRAPHIC tm2132711d1_ex99-2img003.jpg GRAPHIC 233734
11 GRAPHIC tm2132711d1_ex99-2img004.jpg GRAPHIC 275915
12 GRAPHIC tm2132711d1_ex99-2img005.jpg GRAPHIC 222471
13 GRAPHIC tm2132711d1_ex99-2img006.jpg GRAPHIC 335586
14 GRAPHIC tm2132711d1_ex99-2img007.jpg GRAPHIC 216767
15 GRAPHIC tm2132711d1_ex99-2img008.jpg GRAPHIC 140204
16 GRAPHIC tm2132711d1_ex99-2img009.jpg GRAPHIC 326146
17 GRAPHIC tm2132711d1_ex99-2img010.jpg GRAPHIC 164873
18 GRAPHIC tm2132711d1_ex99-2img011.jpg GRAPHIC 228168
19 GRAPHIC tm2132711d1_ex99-2img012.jpg GRAPHIC 178704
20 GRAPHIC tm2132711d1_ex99-2img013.jpg GRAPHIC 146424
21 GRAPHIC tm2132711d1_ex99-2img014.jpg GRAPHIC 352447
22 GRAPHIC tm2132711d1_ex99-2img015.jpg GRAPHIC 244501
23 GRAPHIC tm2132711d1_ex99-2img016.jpg GRAPHIC 330788
24 GRAPHIC tm2132711d1_ex99-2img017.jpg GRAPHIC 195125
25 GRAPHIC tm2132711d1_ex99-2img018.jpg GRAPHIC 213500
26 GRAPHIC tm2132711d1_ex99-2img019.jpg GRAPHIC 169483
27 GRAPHIC tm2132711d1_ex99-2img020.jpg GRAPHIC 366831
28 GRAPHIC tm2132711d1_ex99-2img021.jpg GRAPHIC 222859
29 GRAPHIC tm2132711d1_ex99-2img022.jpg GRAPHIC 314827
30 GRAPHIC tm2132711d1_ex99-2img023.jpg GRAPHIC 220669
31 GRAPHIC tm2132711d1_ex99-2img024.jpg GRAPHIC 375775
32 GRAPHIC tm2132711d1_ex99-2img025.jpg GRAPHIC 155872
33 GRAPHIC tm2132711d1_ex99-2img026.jpg GRAPHIC 223793
34 GRAPHIC tm2132711d1_ex99-2img027.jpg GRAPHIC 110131
35 GRAPHIC tm2132711d1_ex99-2img028.jpg GRAPHIC 276043
36 GRAPHIC tm2132711d1_ex99-2img029.jpg GRAPHIC 523905
  Complete submission text file 0001104659-21-138529.txt   10884658

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zyne-20211115.xsd EX-101.SCH 3186
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyne-20211115_lab.xml EX-101.LAB 34594
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyne-20211115_pre.xml EX-101.PRE 22711
37 EXTRACTED XBRL INSTANCE DOCUMENT tm2132711d1_8k_htm.xml XML 3621
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 211406297
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences